Application 022048

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRIESENCETRIAMCINOLONE ACETONIDEINJECTABLE;INTRAVITREAL40MG/ML (40MG/ML)YesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N022048-001TRIESENCETRIAMCINOLONE ACETONIDE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N022048-00182118802029-03-10U-12572012-08-06
N022048-00182118802029-03-10U-12582012-08-06
N022048-00181289602029-12-17Drug product

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29d4dbc9d85df4…
2026-10-15 13:18:302026-09N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29c2088c7a36db…
2026-09-14 22:38:342026-08N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-2984e616aacf4f…
2026-08-18 06:07:402026-07N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-2987673890dc5c…
2021-03-12 10:30 UTC2021-03N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-293f01610625f2…
2019-09-15 20:21 UTC2019-09N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29b00525d2431f…
2019-07-19 19:46 UTC2019-07N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-293f0d92c62455…
2023-05-13 08:27 UTC2023-05N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-29053a50430f4f…
2023-01-26 05:58 UTC2023-01N022048-001TRIESENCE40MG/ML (40MG/ML)INJECTABLE / INTRAVITREALRLD, RS2007-11-293bdfa0b2c4d7…

Observed Orange Book patent history#

Patent history page 3 of 4 · 141 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2020-12-22 03:56 UTC2020-12N022048-00182118802029-03-10U-12582012-08-068869cabd3fbd…
2020-12-22 03:56 UTC2020-12N022048-00182118802029-03-10U-12572012-08-068869cabd3fbd…
2020-12-22 03:56 UTC2020-12N022048-00181289602029-12-17Drug product8869cabd3fbd…
2020-11-12 02:37 UTC2020-11N022048-00163952942020-01-13U-846Drug productc0c555d07b60…
2020-11-12 02:37 UTC2020-11N022048-00182118802029-03-10U-12582012-08-06c0c555d07b60…
2020-11-12 02:37 UTC2020-11N022048-00182118802029-03-10U-12572012-08-06c0c555d07b60…
2020-11-12 02:37 UTC2020-11N022048-00181289602029-12-17Drug productc0c555d07b60…
2019-12-14 00:12 UTC2019-12N022048-00163952942020-01-13U-846Drug product3f01610625f2…
2019-12-14 00:12 UTC2019-12N022048-00182118802029-03-10U-12582012-08-063f01610625f2…
2019-12-14 00:12 UTC2019-12N022048-00182118802029-03-10U-12572012-08-063f01610625f2…
2019-12-14 00:12 UTC2019-12N022048-00181289602029-12-17Drug product3f01610625f2…
2019-09-15 20:21 UTC2019-09N022048-00163952942020-01-13U-846Drug productb00525d2431f…
2019-09-15 20:21 UTC2019-09N022048-00182118802029-03-10U-12582012-08-06b00525d2431f…
2019-09-15 20:21 UTC2019-09N022048-00182118802029-03-10U-12572012-08-06b00525d2431f…
2019-09-15 20:21 UTC2019-09N022048-00181289602029-12-17Drug productb00525d2431f…
2019-07-19 19:46 UTC2019-07N022048-00163952942020-01-13U-846Drug productea99ee380514…
2019-07-19 19:46 UTC2019-07N022048-00182118802029-03-10U-12582012-08-06ea99ee380514…
2019-07-19 19:46 UTC2019-07N022048-00182118802029-03-10U-12572012-08-06ea99ee380514…
2019-07-19 19:46 UTC2019-07N022048-00181289602029-12-17Drug productea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N022048-00182118802029-03-10U-12582012-08-066a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N022048-00182118802029-03-10U-12572012-08-066a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N022048-00181289602029-12-17Drug product6a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N022048-00182118802029-03-10U-12582012-08-061c564ffb4f44…
2024-02-18 07:12 UTC2024-02N022048-00182118802029-03-10U-12572012-08-061c564ffb4f44…
2024-02-18 07:12 UTC2024-02N022048-00181289602029-12-17Drug product1c564ffb4f44…
2023-12-20 04:57 UTC2023-12N022048-00182118802029-03-10U-12582012-08-06ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N022048-00182118802029-03-10U-12572012-08-06ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N022048-00181289602029-12-17Drug productea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N022048-00182118802029-03-10U-12582012-08-06a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N022048-00182118802029-03-10U-12572012-08-06a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N022048-00181289602029-12-17Drug producta72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N022048-00182118802029-03-10U-12582012-08-069b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N022048-00182118802029-03-10U-12572012-08-069b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N022048-00181289602029-12-17Drug product9b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N022048-00182118802029-03-10U-12572012-08-06a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N022048-00182118802029-03-10U-12582012-08-06a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N022048-00181289602029-12-17Drug producta67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N022048-00182118802029-03-10U-12582012-08-063f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N022048-00182118802029-03-10U-12572012-08-063f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N022048-00181289602029-12-17Drug product3f0d92c62455…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TRIESENCETRIAMCINOLONE ACETONIDEHarrow Eye, LLC2267978c-72ad-9229-e063-6394a90a09d02026-06-05Warnings, Adverse reactionsExact identifier
application applno (NDA): 022048
application number: NDA022048
TRIESENCETRIAMCINOLONE ACETONIDENovartis Pharmaceuticals Corporation22692d92-1359-9252-e063-6394a90ab6692026-04-01Warnings, Adverse reactionsExact identifier
application applno (NDA): 022048
application number: NDA022048

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0065-0543TRIESENCEtriamcinolone acetonideAlcon Laboratories, Inc.NDACurrent
0065-0543TRIESENCEtriamcinolone acetonideAlcon Laboratories, Inc.NDACurrent
0065-0543TRIESENCEtriamcinolone acetonideAlcon Laboratories, Inc.NDACurrent
0065-0543TRIESENCEtriamcinolone acetonideAlcon Laboratories, Inc.NDACurrent
0065-0543TRIESENCEtriamcinolone acetonideAlcon Laboratories, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
42401ORIG2008-07-08
6771ORIG2008-01-09
38146ORIG2007-12-03
53427ORIG1900-01-01
53426ORIG1900-01-01
53425ORIG1900-01-01